Background. Cardiac aging is characterized by a reduced heart rate response to (-agonist stimulation with isoproterenol, but whether the ejection fraction and other cardiovascular responses are reduced in humans is largely unknown. In addition, whether reduced (-agonist responses can be improved with exercise training has not been determined in humans.
In animal models, catecholamine-stimulated heart rate, myocardial contractility, and vasodilatation all decline with age.1"'12 There are fewer data in humans, and many prior studies have been confounded by the failure to rigorously exclude underlying occult cardiovascular disease, which might alter 13-adrenergic responses. Available studies in humans have documented reduced blood pressure or venodilation responses to epinephrine or isoproterenol13'4 and smaller heart rate responses to isoproterenol"3 '5-17 in older than in younger subjects. It is unclear whether other cardiovascular responses, including ejection fraction and cardiac output, are also reduced with aging in humans. A reduction in ,B-adrenergic responses with aging may be an important mechanism for age-associated decreases in cardiovascular performance during exercise stress.
In normal young or older subjects, dynamic exercise training maintains or improves exercise cardiac function, yet resting and submaximal levels of catecholamines are unchanged or reduced, whereas vagal tone may become more dominant.18-2' The maintenance or improvement in exercise cardiac function with reduced catecholamine concentrations suggests that the cardiac response to 13-adrenergic stimulation may be increased with training. However, the extent to which the cardiovascular improvements of training may be a result of improved ,3-adrenergic responses versus other mechanisms, such as training-induced hypertrophy, is unclear. Sensitivity to /3-adrenergic stimulation is clearly affected by exercise training in some systems; for example, training increases ,l-adrenergic-induced lipolysis. 22, 23 Results in animal models have been conflicting, with some training studies suggesting increased cardiovascular catecholamine responses24-27 and others showing no change or a decrease. 28-3' There are only limited and conflicting data regarding training effects on cardiovascular responses to l3-adrenergic stimulation in young humans32-38 and no information in older humans. Information in older subjects is of particular interest because of the reduction in ,3-adrenergic cardiovascular responsiveness that occurs with aging. Several of the changes noted with aging are related to disuse and normalize with increased activity. 39 This study had two purposes. The first was to determine whether rigorously screened sedentary healthy older men indeed do have reduced heart rate, blood pressure, ejection fraction, and cardiac output responses to ff-adrenergic stimulation with isoproterenol compared with healthy young men. The second purpose was to determine whether intensive endurance exercise training increases cardiovascular responses to isoproterenol in either young or older men. To minimize the possibility of underlying occult cardiac disease, which is common in elderly men," we used rigorous cardiac screening techniques. Our years) entered the study and were evaluated before exercise training. Eleven of the young and 13 of the older subjects were also evaluated after exercise training. Six of the young subjects were not restudied for various reasons (withdrawal from training in four, refusal in one, technical problems in one). One of the older subjects underwent baseline testing but did not enter the training program, and one older subject's postexercise training data were not included because of the development of a significant intercurrent illness. The posttraining results, however, are not significantly different if this subject is included. All studies were conducted at least 36 hours after the last episode of exercise training to avoid the acute effects of exercise. This study was approved by the Human Subjects Committee of the University of Washington, and all subjects gave informed consent. Neither the absolute increases in maximal oxygen con- sumption nor the percent increase from baseline was significantly different between the two groups. In the young men after training, absolute heart rate responses to isoproterenol infusions were decreased (p<0.05) (Table 3) . Systolic, diastolic, and mean blood pressure responses to isoproterenol were not altered by training in the young men. In addition, the ejection fraction, peak ejection rate, end-diastolic volume, endsystolic volume, stroke volume, and cardiac output responses to isoproterenol were not altered by training.
In the older men, absolute heart rate responses to isoproterenol infusions were also decreased with training (p<0.05) ( Table 4) . None of the other responses to isoproterenol were altered by training in the older men (systolic or diastolic blood pressure, ejection fraction, peak ejection rate, end-diastolic volume, end-systolic volume, stroke volume, or cardiac output).
The mean plasma isoproterenol concentrations at the various infusion doses (Table 5 ) and the mean resting norepinephrine and epinephrine concentrations were unchanged after training in both groups. The older group had no change in resting plasma norepinephrine concentration (362±+126 pg/ml before versus 313±96 pg/ml after) or in plasma epinephrine concentration (135±26 pg/ml before versus 135±39 pg/ml after) as a result of training. Similarly, the young group had no significant change in resting plasma norepinephrine concentration (261±+79 pg/ml before versus 304±81 pg/ml after) or in plasma epinephrine concentration (77+±39 pg/ml before versus 88±+23 pg/ml after) as a result of training.
Discussion
There are two major findings of this study. First, cardiovascular responses to isoproterenol, including heart rate, ejection fraction, cardiac output, and systolic and diastolic pressures were reduced in healthy older men compared with younger men. Second, exercise training did not augment isoproterenol responses in these healthy men.
Aging and /3-Adrenergic Responses
The autonomic nervous system mediates, at least in part, most cardiovascular responses including preload, contractility, heart rate, afterload, and cardiac output.7-9 '47 With aging, cardiovascular responses to stress are, in general, reduced in both animals and humans.11 '2'47'48 Several factors may contribute to the deficiencies of aging, including occult disease (particularly coronary artery disease), deconditioning, and intrinsic age-associated structural and functional changes. In addition to these factors, however, there is evidence in animal models of an ageassociated reduction in 8-adrenergic-mediated changes in heart rate, vascular tone, and myocardial contractili- ulation is reduced with aging in humans is uncertain. One recent study, in which occult coronary artery disease was not excluded, found a reduced echocardiographically measured shortening fraction response to isoproterenol.56 We found a reduced ejection fraction and peak ejection rate response in older men. The reduced ejection cannot be explained by a greater systolic pressure response, because the systolic pressure actually rose more in the young than the older group; at the highest infusion dose, when the ejection fraction was 10 units higher in the young than in the older group, the systolic pressure was similar (158+21 mm Hg young versus 151+±18 mm Hg older). In addition, the ratio of systolic pressure to end-systolic volume, which partially normalizes for differences in afterload, rose by 280% in the young compared with 88% in the older group. Although none of the measures of contractility used in this study are free of significant limitations, taken together the results suggest a reduced inotropic response of healthy older hearts to ,B-adrenergic stimulation.
Our subjects were thoroughly screened to exclude any overt or occult disease, and a high proportion of older subjects were eliminated because of abnormal screening exercise tolerance tests. Therefore, underlying but undiagnosed disease is an unlikely explanation for our results. The reduced responses of the older group were also probably not a result of differences in circulating isoproterenol concentrations, as marginally higher concentrations were present in the older group, possibly because of a smaller volume of distribution or alterations in clearance. Thus, the present study might have slightly underestimated the age-associated decline in isoproterenol responses.
Another possible explanation for the reduced isoproterenol response at baseline in the older group might be deconditioning. 47 
Limitations
The observed hemodynamic changes represent both the primary effects of the infusion and secondary reflex responses. The relative contributions cannot be determined. Baroreflex sensitivity is decreased with age,75 but differences in baroreflex sensitivity, if anything, might tend to minimize the age differences observed. Vagal inhibition of ventricular function probably occurs in humans. 76 An increase in vagal tone as a result of training (as suggested by the reduced heart rate) might mask any training-induced improvement in isoproterenol responses. Although we consider this unlikely, we cannot exclude this possibility because we did not pretreat with atropine. In addition, our study cannot differentiate /3k-and 82-adrenergic receptor responses.
Conclusions regarding the lack of a training effect in ,B-adrenergic responses must be tempered by the relatively small number of subjects. When all subjects were combined (n = 24), however, there was still no evidence of an enhanced cardiovascular response to isoproterenol after training for any of the measured variables. The ejection fraction is a relatively crude measure of contractility. More precise measures require invasive methods, which were not deemed justifiable in this healthy sample. The reduced ejection fraction during isoproterenol in the older group cannot be explained by differences in heart rate. Increasing the heart rate alone causes no significant change in the ejection fraction.77 In this study, we did not measure maximal ,-adrenergic responses but only submaximal responses because of and conflicting. Heart rate increases with isoproterenol safety concerns.
In conclusion, the heart rate, blood pressure, ejection fraction, and cardiac output responses to graded doses of isoproterenol are reduced in healthy older men. Endurance exercise training does not enhance f-adrenergic responses in either older or young men. Reduced ,f-adrenergic responses probably contribute to the decreased cardiovascular responses to maximal exercise that occur with aging.
